EXHIBIT 23.2

                         CONSENT OF INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" in the
Registration Statement (Form S-3) and related Prospectus of Peregrine
Pharmaceuticals, Inc. for the registration of 12,000,000 shares of its common
stock and to the incorporation by reference therein of our report dated June 20,
2003 (except for Notes 8, 10 and 17, as to which the date is July 2, 2003), with
respect to the consolidated financial statements and schedule of Peregrine
Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year
ended April 30, 2003, filed with the Securities and Exchange Commission.



                                         /s/ ERNST & YOUNG LLP



Orange County, California
October 24, 2003